Blog

Dr. Maloney Discusses Response to JCAR017 CAR T-Cell Therapy – OncLive


OncLive

Dr. Maloney Discusses Response to JCAR017 CAR T-Cell Therapy
OncLive
David Maloney, MD, PhD, professor of medicine, Division of Oncology, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses responses to the chimeric antigen receptor (CAR) T-cell product JCAR017

and more »

2018-01-11 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.